During the past decade, Centre d'étude clinique de Montréal Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre d'étude clinique de Montréal Inc." are "Contraception" (1 trials) and "Metrorrhagia" (1 trials). Many other conditions were trialed in "Centre d'étude clinique de Montréal Inc." in a lesser frequency.

Most popular intervention types in "Centre d'étude clinique de Montréal Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "EV/DNG (Qlaira, BAY86-5027, SH T00658ID)" (1 trials), "Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre d'étude clinique de Montréal Inc." are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre d'étude clinique de Montréal Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centre d'étude clinique de Montréal Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre d'étude clinique de Montréal Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".